

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * viral transcription (GO:0019083) | 9.63206118 |
| 2 | * translational termination (GO:0006415) | 9.29840434 |
| 3 | ribosomal small subunit assembly (GO:0000028) | 8.40393149 |
| 4 | ribosomal small subunit biogenesis (GO:0042274) | 8.38693530 |
| 5 | * SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 8.22609157 |
| 6 | * cotranslational protein targeting to membrane (GO:0006613) | 8.08820517 |
| 7 | * protein targeting to ER (GO:0045047) | 8.07219507 |
| 8 | * translational elongation (GO:0006414) | 7.94464392 |
| 9 | * establishment of protein localization to endoplasmic reticulum (GO:0072599) | 7.72788116 |
| 10 | * protein localization to endoplasmic reticulum (GO:0070972) | 7.55130728 |
| 11 | * viral life cycle (GO:0019058) | 7.25571292 |
| 12 | * nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 7.25550826 |
| 13 | * cellular protein complex disassembly (GO:0043624) | 7.20262811 |
| 14 | * translational initiation (GO:0006413) | 6.94946860 |
| 15 | maturation of SSU-rRNA (GO:0030490) | 6.82545100 |
| 16 | * protein complex disassembly (GO:0043241) | 6.26737167 |
| 17 | ribosomal large subunit biogenesis (GO:0042273) | 6.20717636 |
| 18 | * macromolecular complex disassembly (GO:0032984) | 5.85242452 |
| 19 | * protein targeting to membrane (GO:0006612) | 5.40148442 |
| 20 | * nuclear-transcribed mRNA catabolic process (GO:0000956) | 5.17725859 |
| 21 | * translation (GO:0006412) | 5.13270210 |
| 22 | * mRNA catabolic process (GO:0006402) | 4.90385551 |
| 23 | formation of translation preinitiation complex (GO:0001731) | 4.64666828 |
| 24 | ribonucleoprotein complex biogenesis (GO:0022613) | 4.64459750 |
| 25 | * RNA catabolic process (GO:0006401) | 4.56747644 |
| 26 | * establishment of protein localization to membrane (GO:0090150) | 3.68555307 |
| 27 | rRNA processing (GO:0006364) | 3.66731860 |
| 28 | rRNA metabolic process (GO:0016072) | 3.52493239 |
| 29 | cellular component biogenesis (GO:0044085) | 3.48124175 |
| 30 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.47006693 |
| 31 | DNA unwinding involved in DNA replication (GO:0006268) | 3.40835322 |
| 32 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.38039150 |
| 33 | * establishment of protein localization to organelle (GO:0072594) | 3.34295049 |
| 34 | * protein targeting (GO:0006605) | 3.34142012 |
| 35 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.33834718 |
| 36 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.32901470 |
| 37 | negative thymic T cell selection (GO:0045060) | 3.32380088 |
| 38 | positive thymic T cell selection (GO:0045059) | 3.32273637 |
| 39 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.30962299 |
| 40 | negative T cell selection (GO:0043383) | 3.29157631 |
| 41 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.28937270 |
| 42 | DNA strand elongation (GO:0022616) | 3.27370750 |
| 43 | establishment of integrated proviral latency (GO:0075713) | 3.27245558 |
| 44 | DNA deamination (GO:0045006) | 3.24412540 |
| 45 | thymic T cell selection (GO:0045061) | 3.17577854 |
| 46 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.11654105 |
| 47 | ATP synthesis coupled proton transport (GO:0015986) | 3.11654105 |
| 48 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.11639411 |
| 49 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.03646488 |
| 50 | negative regulation of RNA splicing (GO:0033119) | 2.99065499 |
| 51 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.98904597 |
| 52 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.93827452 |
| 53 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.88572148 |
| 54 | telomere maintenance via recombination (GO:0000722) | 2.86806253 |
| 55 | DNA replication initiation (GO:0006270) | 2.86163453 |
| 56 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.82471276 |
| 57 | UTP biosynthetic process (GO:0006228) | 2.81706613 |
| 58 | spliceosomal snRNP assembly (GO:0000387) | 2.80374474 |
| 59 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.78098744 |
| 60 | ribosome assembly (GO:0042255) | 2.75785950 |
| 61 | positive T cell selection (GO:0043368) | 2.74534498 |
| 62 | T cell selection (GO:0045058) | 2.73553271 |
| 63 | ncRNA 3-end processing (GO:0043628) | 2.72334296 |
| 64 | viral protein processing (GO:0019082) | 2.71693293 |
| 65 | regulation of protein heterodimerization activity (GO:0043497) | 2.71482102 |
| 66 | * protein localization to membrane (GO:0072657) | 2.71007337 |
| 67 | positive regulation of B cell differentiation (GO:0045579) | 2.69732598 |
| 68 | negative regulation of ligase activity (GO:0051352) | 2.68859890 |
| 69 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.68859890 |
| 70 | mitotic recombination (GO:0006312) | 2.68695902 |
| 71 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.68150287 |
| 72 | establishment of viral latency (GO:0019043) | 2.67968438 |
| 73 | nucleobase biosynthetic process (GO:0046112) | 2.67889552 |
| 74 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.67671706 |
| 75 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.66375554 |
| 76 | ribosome biogenesis (GO:0042254) | 2.65817275 |
| 77 | tolerance induction (GO:0002507) | 2.65635003 |
| 78 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.65453745 |
| 79 | negative regulation of cell killing (GO:0031342) | 2.65453745 |
| 80 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.64712675 |
| 81 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.63087826 |
| 82 | proteasome assembly (GO:0043248) | 2.63044677 |
| 83 | * gene expression (GO:0010467) | 2.62926928 |
| 84 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.62545217 |
| 85 | GTP biosynthetic process (GO:0006183) | 2.62174329 |
| 86 | protein localization to kinetochore (GO:0034501) | 2.61863915 |
| 87 | * cellular component disassembly (GO:0022411) | 2.60972277 |
| 88 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.60721859 |
| 89 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.60710843 |
| 90 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.60710843 |
| 91 | leukocyte aggregation (GO:0070486) | 2.60513159 |
| 92 | spliceosomal complex assembly (GO:0000245) | 2.59905053 |
| 93 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.59253514 |
| 94 | myeloid cell homeostasis (GO:0002262) | 2.58975145 |
| 95 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.57724183 |
| 96 | positive regulation of granulocyte differentiation (GO:0030854) | 2.57195330 |
| 97 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.55433148 |
| 98 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.55433148 |
| 99 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.55433148 |
| 100 | telomere maintenance via telomere lengthening (GO:0010833) | 2.55415025 |
| 101 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.55052692 |
| 102 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.55052692 |
| 103 | pseudouridine synthesis (GO:0001522) | 2.54166746 |
| 104 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.53902862 |
| 105 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.53539790 |
| 106 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.52097574 |
| 107 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.52003599 |
| 108 | UTP metabolic process (GO:0046051) | 2.51013368 |
| 109 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.50291300 |
| 110 | termination of RNA polymerase III transcription (GO:0006386) | 2.50291300 |
| 111 | T cell apoptotic process (GO:0070231) | 2.50128453 |
| 112 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.49903098 |
| 113 | * protein localization to organelle (GO:0033365) | 2.49244355 |
| 114 | modulation by virus of host process (GO:0019054) | 2.48220204 |
| 115 | cellular response to interleukin-4 (GO:0071353) | 2.47754543 |
| 116 | ncRNA processing (GO:0034470) | 2.47713409 |
| 117 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.45887495 |
| 118 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.43204547 |
| 119 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.43204547 |
| 120 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.42943954 |
| 121 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.40947423 |
| 122 | ribonucleoprotein complex assembly (GO:0022618) | 2.40833844 |
| 123 | mitotic nuclear envelope disassembly (GO:0007077) | 2.39625134 |
| 124 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.38380804 |
| 125 | Peyers patch development (GO:0048541) | 2.38187608 |
| 126 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.38187608 |
| 127 | IMP biosynthetic process (GO:0006188) | 2.38167113 |
| 128 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.37873958 |
| 129 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.37177649 |
| 130 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.36539046 |
| 131 | CTP biosynthetic process (GO:0006241) | 2.35930324 |
| 132 | CTP metabolic process (GO:0046036) | 2.35930324 |
| 133 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.34447858 |
| 134 | pentose metabolic process (GO:0019321) | 2.32707481 |
| 135 | GDP-mannose metabolic process (GO:0019673) | 2.32420088 |
| 136 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.30598882 |
| 137 | oxidative phosphorylation (GO:0006119) | 2.29543791 |
| 138 | regulation of translational fidelity (GO:0006450) | 2.27986775 |
| 139 | virion assembly (GO:0019068) | 2.26246699 |
| 140 | response to interleukin-4 (GO:0070670) | 2.23648867 |
| 141 | NIK/NF-kappaB signaling (GO:0038061) | 2.22837800 |
| 142 | viral mRNA export from host cell nucleus (GO:0046784) | 2.22041393 |
| 143 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.21156443 |
| 144 | regulation of B cell differentiation (GO:0045577) | 2.20613068 |
| 145 | regulation of gamma-delta T cell activation (GO:0046643) | 2.17771480 |
| 146 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.17200943 |
| 147 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.16739338 |
| 148 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.16556941 |
| 149 | positive regulation by symbiont of host defense response (GO:0052509) | 2.16472338 |
| 150 | modulation by symbiont of host defense response (GO:0052031) | 2.16472338 |
| 151 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.16472338 |
| 152 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.16472338 |
| 153 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.16472338 |
| 154 | modulation by symbiont of host immune response (GO:0052553) | 2.16472338 |
| 155 | negative regulation of phagocytosis (GO:0050765) | 2.15773202 |
| 156 | pentose-phosphate shunt (GO:0006098) | 2.13976038 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.76568456 |
| 2 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.72768427 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.04339330 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.73884969 |
| 5 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 3.36606833 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.29026638 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.25318149 |
| 8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.98861261 |
| 9 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.92642917 |
| 10 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.81329878 |
| 11 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.73771754 |
| 12 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.67984926 |
| 13 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.62144388 |
| 14 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.61897785 |
| 15 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.60301800 |
| 16 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.50737811 |
| 17 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.47499549 |
| 18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.43089997 |
| 19 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.38312147 |
| 20 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.34002504 |
| 21 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.33320519 |
| 22 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.30050975 |
| 23 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.21019865 |
| 24 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.18555719 |
| 25 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.17445784 |
| 26 | * TTF2_22483619_ChIP-Seq_HELA_Human | 2.17092716 |
| 27 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.08125240 |
| 28 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.03945660 |
| 29 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 2.01748256 |
| 30 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.01131551 |
| 31 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00729538 |
| 32 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.97344030 |
| 33 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.90659954 |
| 34 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.88768933 |
| 35 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.73540634 |
| 36 | MAF_26560356_Chip-Seq_TH1_Human | 1.72872718 |
| 37 | MYC_22102868_ChIP-Seq_BL_Human | 1.70072318 |
| 38 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.65447704 |
| 39 | UTX_26944678_Chip-Seq_JUKART_Human | 1.65263076 |
| 40 | MAF_26560356_Chip-Seq_TH2_Human | 1.62879313 |
| 41 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.62735070 |
| 42 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.60531158 |
| 43 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.56988352 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52223848 |
| 45 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.51312249 |
| 46 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.50993328 |
| 47 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.50020704 |
| 48 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.49646833 |
| 49 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.48983103 |
| 50 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.48055869 |
| 51 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.46876635 |
| 52 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.43948993 |
| 53 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.43646430 |
| 54 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.42648452 |
| 55 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.42487788 |
| 56 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.41911873 |
| 57 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40852668 |
| 58 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.40323794 |
| 59 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.40149179 |
| 60 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.39500548 |
| 61 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.36465297 |
| 62 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.36413939 |
| 63 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.36002327 |
| 64 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.32331246 |
| 65 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.31754199 |
| 66 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30524748 |
| 67 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.27977432 |
| 68 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.26273954 |
| 69 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.24598884 |
| 70 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.24582202 |
| 71 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.24528042 |
| 72 | * KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.24460690 |
| 73 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.24458993 |
| 74 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.24233488 |
| 75 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.24172859 |
| 76 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.23900051 |
| 77 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.23361374 |
| 78 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.22729548 |
| 79 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.22595954 |
| 80 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.21974910 |
| 81 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.20987078 |
| 82 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.20319896 |
| 83 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.18687785 |
| 84 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.17793257 |
| 85 | * MYB_26560356_Chip-Seq_TH2_Human | 1.17510656 |
| 86 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.17243537 |
| 87 | MYB_26560356_Chip-Seq_TH1_Human | 1.16995561 |
| 88 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.16832478 |
| 89 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.16448001 |
| 90 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.16337477 |
| 91 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.16203231 |
| 92 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.13892427 |
| 93 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13825948 |
| 94 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13545433 |
| 95 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13276086 |
| 96 | P68_20966046_ChIP-Seq_HELA_Human | 1.12374072 |
| 97 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.12234847 |
| 98 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.12226571 |
| 99 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.10291706 |
| 100 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.10092191 |
| 101 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.09499688 |
| 102 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.08807169 |
| 103 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.07718600 |
| 104 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.07202488 |
| 105 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.07075021 |
| 106 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.06844619 |
| 107 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.04811948 |
| 108 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.04722791 |
| 109 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.04399646 |
| 110 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.04355221 |
| 111 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.04067882 |
| 112 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.03899211 |
| 113 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03519754 |
| 114 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.01951323 |
| 115 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.00808467 |
| 116 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.99530014 |
| 117 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.99252027 |
| 118 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.97908320 |
| 119 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.97159412 |
| 120 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.97098791 |
| 121 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.96741761 |
| 122 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.96658786 |
| 123 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.96522824 |
| 124 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.92911830 |
| 125 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.91515651 |
| 126 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.90758102 |
| 127 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.90217623 |
| 128 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90080435 |
| 129 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.88792858 |
| 130 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88650868 |
| 131 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.87182608 |
| 132 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.87182608 |
| 133 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.87182608 |
| 134 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.86138101 |
| 135 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.85930930 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.41532297 |
| 2 | MP0009379_abnormal_foot_pigmentation | 4.27287451 |
| 3 | MP0004957_abnormal_blastocyst_morpholog | 3.46061339 |
| 4 | MP0003077_abnormal_cell_cycle | 2.68197863 |
| 5 | MP0010094_abnormal_chromosome_stability | 2.43058922 |
| 6 | MP0010352_gastrointestinal_tract_polyps | 2.39205073 |
| 7 | MP0008057_abnormal_DNA_replication | 2.29904321 |
| 8 | MP0003111_abnormal_nucleus_morphology | 2.28544798 |
| 9 | MP0002396_abnormal_hematopoietic_system | 2.25602238 |
| 10 | MP0000490_abnormal_crypts_of | 1.99362497 |
| 11 | MP0008932_abnormal_embryonic_tissue | 1.96451655 |
| 12 | MP0009333_abnormal_splenocyte_physiolog | 1.88530768 |
| 13 | MP0008007_abnormal_cellular_replicative | 1.85406142 |
| 14 | MP0009278_abnormal_bone_marrow | 1.73552885 |
| 15 | MP0004808_abnormal_hematopoietic_stem | 1.70084696 |
| 16 | MP0006054_spinal_hemorrhage | 1.66609275 |
| 17 | MP0003763_abnormal_thymus_physiology | 1.64217294 |
| 18 | MP0008058_abnormal_DNA_repair | 1.63638748 |
| 19 | MP0001730_embryonic_growth_arrest | 1.60777186 |
| 20 | MP0002166_altered_tumor_susceptibility | 1.60390978 |
| 21 | MP0008995_early_reproductive_senescence | 1.59284215 |
| 22 | MP0000350_abnormal_cell_proliferation | 1.57462262 |
| 23 | MP0003123_paternal_imprinting | 1.53678255 |
| 24 | MP0002009_preneoplasia | 1.50783478 |
| 25 | MP0003806_abnormal_nucleotide_metabolis | 1.46313652 |
| 26 | MP0001835_abnormal_antigen_presentation | 1.43348373 |
| 27 | MP0000858_altered_metastatic_potential | 1.42247506 |
| 28 | MP0000685_abnormal_immune_system | 1.41989712 |
| 29 | MP0008260_abnormal_autophagy | 1.40890764 |
| 30 | MP0003567_abnormal_fetal_cardiomyocyte | 1.38662680 |
| 31 | MP0002419_abnormal_innate_immunity | 1.37603760 |
| 32 | MP0002398_abnormal_bone_marrow | 1.33437425 |
| 33 | MP0002938_white_spotting | 1.29988461 |
| 34 | MP0002019_abnormal_tumor_incidence | 1.29759046 |
| 35 | MP0000678_abnormal_parathyroid_gland | 1.29657192 |
| 36 | MP0002722_abnormal_immune_system | 1.28417912 |
| 37 | MP0002277_abnormal_respiratory_mucosa | 1.28274575 |
| 38 | MP0001800_abnormal_humoral_immune | 1.27308339 |
| 39 | MP0003786_premature_aging | 1.24375023 |
| 40 | MP0005220_abnormal_exocrine_pancreas | 1.24366552 |
| 41 | MP0002006_tumorigenesis | 1.23959672 |
| 42 | MP0005451_abnormal_body_composition | 1.23153237 |
| 43 | MP0004381_abnormal_hair_follicle | 1.22503124 |
| 44 | MP0001697_abnormal_embryo_size | 1.22472921 |
| 45 | MP0000703_abnormal_thymus_morphology | 1.21608707 |
| 46 | MP0000689_abnormal_spleen_morphology | 1.20406690 |
| 47 | MP0004185_abnormal_adipocyte_glucose | 1.20083511 |
| 48 | MP0003436_decreased_susceptibility_to | 1.17922983 |
| 49 | MP0005174_abnormal_tail_pigmentation | 1.17513017 |
| 50 | MP0002080_prenatal_lethality | 1.15416592 |
| 51 | MP0000313_abnormal_cell_death | 1.14666856 |
| 52 | MP0003186_abnormal_redox_activity | 1.13775353 |
| 53 | MP0002163_abnormal_gland_morphology | 1.12667746 |
| 54 | MP0002429_abnormal_blood_cell | 1.11404697 |
| 55 | MP0002452_abnormal_antigen_presenting | 1.11055372 |
| 56 | MP0002405_respiratory_system_inflammati | 1.10623626 |
| 57 | MP0001545_abnormal_hematopoietic_system | 1.09827826 |
| 58 | MP0005397_hematopoietic_system_phenotyp | 1.09827826 |
| 59 | MP0005671_abnormal_response_to | 1.09447714 |
| 60 | MP0002420_abnormal_adaptive_immunity | 1.09385770 |
| 61 | MP0001853_heart_inflammation | 1.08513014 |
| 62 | MP0009785_altered_susceptibility_to | 1.07519891 |
| 63 | MP0000716_abnormal_immune_system | 1.07233184 |
| 64 | MP0002796_impaired_skin_barrier | 1.07114618 |
| 65 | MP0005000_abnormal_immune_tolerance | 1.07112952 |
| 66 | MP0001819_abnormal_immune_cell | 1.07047931 |
| 67 | MP0003191_abnormal_cellular_cholesterol | 1.05541890 |
| 68 | MP0000358_abnormal_cell_content/ | 1.05142681 |
| 69 | MP0003303_peritoneal_inflammation | 1.04956250 |
| 70 | MP0003866_abnormal_defecation | 1.04505506 |
| 71 | MP0002723_abnormal_immune_serum | 1.03978395 |
| 72 | MP0005025_abnormal_response_to | 1.03757289 |
| 73 | MP0002933_joint_inflammation | 1.02353231 |
| 74 | MP0001873_stomach_inflammation | 1.01677777 |
| 75 | MP0005023_abnormal_wound_healing | 1.01035541 |
| 76 | MP0010307_abnormal_tumor_latency | 1.00295164 |
| 77 | MP0001672_abnormal_embryogenesis/_devel | 1.00073557 |
| 78 | MP0005380_embryogenesis_phenotype | 1.00073557 |
| 79 | MP0004197_abnormal_fetal_growth/weight/ | 0.97577500 |
| 80 | MP0002086_abnormal_extraembryonic_tissu | 0.96899781 |
| 81 | MP0010155_abnormal_intestine_physiology | 0.96684087 |
| 82 | MP0000465_gastrointestinal_hemorrhage | 0.95709507 |
| 83 | MP0006036_abnormal_mitochondrial_physio | 0.94467911 |
| 84 | MP0003300_gastrointestinal_ulcer | 0.93441105 |
| 85 | MP0002088_abnormal_embryonic_growth/wei | 0.92855424 |
| 86 | MP0002084_abnormal_developmental_patter | 0.92824521 |
| 87 | MP0002085_abnormal_embryonic_tissue | 0.92679594 |
| 88 | MP0002249_abnormal_larynx_morphology | 0.92413189 |
| 89 | MP0003984_embryonic_growth_retardation | 0.91659506 |
| 90 | MP0010030_abnormal_orbit_morphology | 0.90961366 |
| 91 | MP0002132_abnormal_respiratory_system | 0.90736957 |
| 92 | MP0005083_abnormal_biliary_tract | 0.90512471 |
| 93 | MP0002148_abnormal_hypersensitivity_rea | 0.89367583 |
| 94 | MP0005408_hypopigmentation | 0.87962050 |
| 95 | MP0003315_abnormal_perineum_morphology | 0.84863435 |
| 96 | MP0001663_abnormal_digestive_system | 0.84487924 |
| 97 | MP0005076_abnormal_cell_differentiation | 0.84205947 |
| 98 | MP0002095_abnormal_skin_pigmentation | 0.82095827 |
| 99 | MP0001790_abnormal_immune_system | 0.81888604 |
| 100 | MP0005387_immune_system_phenotype | 0.81888604 |
| 101 | MP0003941_abnormal_skin_development | 0.81262589 |
| 102 | MP0000477_abnormal_intestine_morphology | 0.80855443 |
| 103 | MP0003566_abnormal_cell_adhesion | 0.80012571 |
| 104 | MP0001533_abnormal_skeleton_physiology | 0.79867471 |
| 105 | MP0001845_abnormal_inflammatory_respons | 0.78584766 |
| 106 | MP0008469_abnormal_protein_level | 0.78482012 |
| 107 | MP0003724_increased_susceptibility_to | 0.78479343 |
| 108 | MP0000613_abnormal_salivary_gland | 0.77889486 |
| 109 | MP0002877_abnormal_melanocyte_morpholog | 0.77550349 |
| 110 | MP0001346_abnormal_lacrimal_gland | 0.77347399 |
| 111 | MP0000537_abnormal_urethra_morphology | 0.76247261 |
| 112 | MP0009931_abnormal_skin_appearance | 0.76166931 |
| 113 | MP0005501_abnormal_skin_physiology | 0.75842529 |
| 114 | MP0001851_eye_inflammation | 0.75137076 |
| 115 | MP0005058_abnormal_lysosome_morphology | 0.73888916 |
| 116 | MP0005379_endocrine/exocrine_gland_phen | 0.73061141 |
| 117 | MP0000372_irregular_coat_pigmentation | 0.73013399 |
| 118 | MP0005464_abnormal_platelet_physiology | 0.72609768 |
| 119 | MP0005381_digestive/alimentary_phenotyp | 0.72524095 |
| 120 | MP0004264_abnormal_extraembryonic_tissu | 0.72202312 |
| 121 | MP0005075_abnormal_melanosome_morpholog | 0.72137124 |
| 122 | MP0004947_skin_inflammation | 0.71549603 |
| 123 | MP0001293_anophthalmia | 0.71283315 |
| 124 | MP0000750_abnormal_muscle_regeneration | 0.70040291 |
| 125 | MP0000681_abnormal_thyroid_gland | 0.69586547 |
| 126 | MP0003448_altered_tumor_morphology | 0.69334383 |
| 127 | MP0008438_abnormal_cutaneous_collagen | 0.67938723 |
| 128 | MP0006035_abnormal_mitochondrial_morpho | 0.66953583 |
| 129 | MP0009053_abnormal_anal_canal | 0.66403128 |
| 130 | MP0001881_abnormal_mammary_gland | 0.65162392 |
| 131 | MP0001348_abnormal_lacrimal_gland | 0.65106018 |
| 132 | MP0005390_skeleton_phenotype | 0.64141471 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 9.08272406 |
| 2 | Reticulocytopenia (HP:0001896) | 7.75487175 |
| 3 | Abnormal number of erythroid precursors (HP:0012131) | 7.70088185 |
| 4 | Macrocytic anemia (HP:0001972) | 6.07450804 |
| 5 | Pallor (HP:0000980) | 5.87919940 |
| 6 | Panhypogammaglobulinemia (HP:0003139) | 4.19408289 |
| 7 | Abnormal hemoglobin (HP:0011902) | 4.04641964 |
| 8 | Aplastic anemia (HP:0001915) | 4.04117496 |
| 9 | Agammaglobulinemia (HP:0004432) | 3.79999700 |
| 10 | Thrombocytosis (HP:0001894) | 3.53364934 |
| 11 | Colon cancer (HP:0003003) | 3.44576795 |
| 12 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.31254098 |
| 13 | Multiple enchondromatosis (HP:0005701) | 3.21280018 |
| 14 | Seborrheic dermatitis (HP:0001051) | 3.11657937 |
| 15 | Hypertensive crisis (HP:0100735) | 3.07290725 |
| 16 | Recurrent viral infections (HP:0004429) | 3.03394549 |
| 17 | Obstructive lung disease (HP:0006536) | 2.97850715 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 2.97850715 |
| 19 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.95315890 |
| 20 | 11 pairs of ribs (HP:0000878) | 2.91241483 |
| 21 | Eczematoid dermatitis (HP:0000976) | 2.88917620 |
| 22 | Trismus (HP:0000211) | 2.84176071 |
| 23 | Stenosis of the external auditory canal (HP:0000402) | 2.83171102 |
| 24 | Colitis (HP:0002583) | 2.79073386 |
| 25 | Increased IgE level (HP:0003212) | 2.78057833 |
| 26 | Recurrent abscess formation (HP:0002722) | 2.70107162 |
| 27 | Absent thumb (HP:0009777) | 2.69344612 |
| 28 | IgM deficiency (HP:0002850) | 2.68868583 |
| 29 | Meningitis (HP:0001287) | 2.68123728 |
| 30 | Increased intramyocellular lipid droplets (HP:0012240) | 2.67888906 |
| 31 | Recurrent bacterial skin infections (HP:0005406) | 2.66780033 |
| 32 | Abnormality of reticulocytes (HP:0004312) | 2.63997031 |
| 33 | Recurrent fungal infections (HP:0002841) | 2.62030286 |
| 34 | Gastrointestinal inflammation (HP:0004386) | 2.61398622 |
| 35 | Oral leukoplakia (HP:0002745) | 2.57688706 |
| 36 | Depressed nasal ridge (HP:0000457) | 2.53461202 |
| 37 | Increased muscle lipid content (HP:0009058) | 2.52935254 |
| 38 | Papilloma (HP:0012740) | 2.51653097 |
| 39 | Verrucae (HP:0200043) | 2.51653097 |
| 40 | Glossoptosis (HP:0000162) | 2.49705535 |
| 41 | Selective tooth agenesis (HP:0001592) | 2.44987670 |
| 42 | Carpal bone hypoplasia (HP:0001498) | 2.41906091 |
| 43 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.37440303 |
| 44 | Recurrent cutaneous fungal infections (HP:0011370) | 2.37440303 |
| 45 | Inflammation of the large intestine (HP:0002037) | 2.36084346 |
| 46 | Increased IgM level (HP:0003496) | 2.34755956 |
| 47 | Cellulitis (HP:0100658) | 2.34342445 |
| 48 | Granulocytopenia (HP:0001913) | 2.31782160 |
| 49 | Congenital, generalized hypertrichosis (HP:0004540) | 2.30143642 |
| 50 | Pustule (HP:0200039) | 2.27797418 |
| 51 | Increased hepatocellular lipid droplets (HP:0006565) | 2.27586141 |
| 52 | Rough bone trabeculation (HP:0100670) | 2.26161982 |
| 53 | Thick lower lip vermilion (HP:0000179) | 2.25969802 |
| 54 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.25421853 |
| 55 | Villous atrophy (HP:0011473) | 2.25421853 |
| 56 | Microretrognathia (HP:0000308) | 2.24837007 |
| 57 | Severe combined immunodeficiency (HP:0004430) | 2.21498151 |
| 58 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.21467374 |
| 59 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.21467374 |
| 60 | Type I transferrin isoform profile (HP:0003642) | 2.21454748 |
| 61 | Lymphopenia (HP:0001888) | 2.19612728 |
| 62 | Exertional dyspnea (HP:0002875) | 2.16713223 |
| 63 | Encephalitis (HP:0002383) | 2.13606939 |
| 64 | Myositis (HP:0100614) | 2.12884549 |
| 65 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.11573250 |
| 66 | Viral hepatitis (HP:0006562) | 2.11177021 |
| 67 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.08694897 |
| 68 | Mitochondrial inheritance (HP:0001427) | 2.06624066 |
| 69 | Gastrointestinal stroma tumor (HP:0100723) | 2.06019549 |
| 70 | Migraine (HP:0002076) | 2.04722200 |
| 71 | Abnormality of the parietal bone (HP:0002696) | 2.04541919 |
| 72 | Gastrointestinal infarctions (HP:0005244) | 2.04115965 |
| 73 | Acute necrotizing encephalopathy (HP:0006965) | 2.03688120 |
| 74 | Recurrent skin infections (HP:0001581) | 2.03359340 |
| 75 | Mediastinal lymphadenopathy (HP:0100721) | 2.03040384 |
| 76 | Missing ribs (HP:0000921) | 2.02699286 |
| 77 | Ragged-red muscle fibers (HP:0003200) | 2.02691166 |
| 78 | Truncus arteriosus (HP:0001660) | 2.01040822 |
| 79 | Hypoplasia of the radius (HP:0002984) | 1.99348238 |
| 80 | Spinal cord lesions (HP:0100561) | 1.98802497 |
| 81 | Syringomyelia (HP:0003396) | 1.98802497 |
| 82 | Lipid accumulation in hepatocytes (HP:0006561) | 1.98350063 |
| 83 | Myelodysplasia (HP:0002863) | 1.97873100 |
| 84 | Breast hypoplasia (HP:0003187) | 1.96932408 |
| 85 | Broad distal phalanx of finger (HP:0009836) | 1.96638735 |
| 86 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.93358763 |
| 87 | Premature skin wrinkling (HP:0100678) | 1.93344647 |
| 88 | Bicuspid aortic valve (HP:0001647) | 1.90941178 |
| 89 | Basal cell carcinoma (HP:0002671) | 1.90327885 |
| 90 | Atresia of the external auditory canal (HP:0000413) | 1.89368118 |
| 91 | Triphalangeal thumb (HP:0001199) | 1.88422905 |
| 92 | Neoplasm of the pancreas (HP:0002894) | 1.87832354 |
| 93 | Fatigue (HP:0012378) | 1.87007312 |
| 94 | Petechiae (HP:0000967) | 1.86609042 |
| 95 | Muscle fiber atrophy (HP:0100295) | 1.85546480 |
| 96 | Recurrent bronchitis (HP:0002837) | 1.80799401 |
| 97 | Neutropenia (HP:0001875) | 1.80617122 |
| 98 | Skin rash (HP:0000988) | 1.79946755 |
| 99 | Birth length less than 3rd percentile (HP:0003561) | 1.79200008 |
| 100 | Myopathic facies (HP:0002058) | 1.78998423 |
| 101 | Lymphoma (HP:0002665) | 1.78771222 |
| 102 | Mesangial abnormality (HP:0001966) | 1.77961842 |
| 103 | Vacuolated lymphocytes (HP:0001922) | 1.77698808 |
| 104 | Autoimmune hemolytic anemia (HP:0001890) | 1.77452606 |
| 105 | Abnormal number of incisors (HP:0011064) | 1.76312200 |
| 106 | Hepatocellular necrosis (HP:0001404) | 1.75547218 |
| 107 | Increased CSF lactate (HP:0002490) | 1.75445933 |
| 108 | Combined immunodeficiency (HP:0005387) | 1.75387465 |
| 109 | Hypergammaglobulinemia (HP:0010702) | 1.72313954 |
| 110 | Orthostatic hypotension (HP:0001278) | 1.72185042 |
| 111 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.71773269 |
| 112 | Vasculitis (HP:0002633) | 1.71694249 |
| 113 | Polygenic inheritance (HP:0010982) | 1.71653635 |
| 114 | IgG deficiency (HP:0004315) | 1.71015420 |
| 115 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.71014561 |
| 116 | Exercise intolerance (HP:0003546) | 1.70565555 |
| 117 | Asplenia (HP:0001746) | 1.70318200 |
| 118 | Hypoproteinemia (HP:0003075) | 1.70078312 |
| 119 | Stomatitis (HP:0010280) | 1.69605731 |
| 120 | Degeneration of anterior horn cells (HP:0002398) | 1.69294269 |
| 121 | Abnormality of the anterior horn cell (HP:0006802) | 1.69294269 |
| 122 | Agnosia (HP:0010524) | 1.68988701 |
| 123 | Abnormal trabecular bone morphology (HP:0100671) | 1.68938849 |
| 124 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.68581151 |
| 125 | Proximal placement of thumb (HP:0009623) | 1.67917174 |
| 126 | Thoracolumbar scoliosis (HP:0002944) | 1.67667339 |
| 127 | Poikiloderma (HP:0001029) | 1.67037899 |
| 128 | Abnormality of T cell physiology (HP:0011840) | 1.66717529 |
| 129 | Microvesicular hepatic steatosis (HP:0001414) | 1.64897136 |
| 130 | Respiratory difficulties (HP:0002880) | 1.64575857 |
| 131 | Amaurosis fugax (HP:0100576) | 1.63427556 |
| 132 | Abnormal protein glycosylation (HP:0012346) | 1.63299584 |
| 133 | Abnormal glycosylation (HP:0012345) | 1.63299584 |
| 134 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.63299584 |
| 135 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.63299584 |
| 136 | Poor head control (HP:0002421) | 1.63072434 |
| 137 | Pancytopenia (HP:0001876) | 1.63026092 |
| 138 | Woolly hair (HP:0002224) | 1.61728243 |
| 139 | Deviation of the thumb (HP:0009603) | 1.61685890 |
| 140 | Progressive muscle weakness (HP:0003323) | 1.60149203 |
| 141 | Cleft eyelid (HP:0000625) | 1.59236531 |
| 142 | 3-Methylglutaconic aciduria (HP:0003535) | 1.57657382 |
| 143 | Increased density of long bones (HP:0006392) | 1.57653586 |
| 144 | Sparse lateral eyebrow (HP:0005338) | 1.57438885 |
| 145 | Reduced antithrombin III activity (HP:0001976) | 1.56737032 |
| 146 | Premature graying of hair (HP:0002216) | 1.56047686 |
| 147 | Squamous cell carcinoma (HP:0002860) | 1.55993049 |
| 148 | Abnormality of the preputium (HP:0100587) | 1.55540881 |
| 149 | Broad face (HP:0000283) | 1.54950177 |
| 150 | Abnormality of T cells (HP:0002843) | 1.53923368 |
| 151 | Patellar aplasia (HP:0006443) | 1.53144465 |
| 152 | Vertebral hypoplasia (HP:0008417) | 1.52250163 |
| 153 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.52250163 |
| 154 | Rectal prolapse (HP:0002035) | 1.52218582 |
| 155 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.51555193 |
| 156 | Renal Fanconi syndrome (HP:0001994) | 1.50440670 |
| 157 | Hepatic necrosis (HP:0002605) | 1.50140727 |
| 158 | Progressive macrocephaly (HP:0004481) | 1.48571983 |
| 159 | Bone marrow hypocellularity (HP:0005528) | 1.45927511 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 5.65075764 |
| 2 | VRK2 | 3.87244047 |
| 3 | SMG1 | 3.31700333 |
| 4 | PRPF4B | 3.04249231 |
| 5 | BUB1 | 3.03007073 |
| 6 | TRIB3 | 2.87913945 |
| 7 | RPS6KB2 | 2.86503262 |
| 8 | WEE1 | 2.85917081 |
| 9 | EEF2K | 2.68351198 |
| 10 | PASK | 2.48138046 |
| 11 | PIM2 | 2.40955320 |
| 12 | LRRK2 | 2.36998746 |
| 13 | TGFBR1 | 2.31802555 |
| 14 | EIF2AK3 | 2.28176423 |
| 15 | EIF2AK1 | 2.12625004 |
| 16 | CDC7 | 2.04619687 |
| 17 | STK16 | 1.82152361 |
| 18 | FLT3 | 1.80671402 |
| 19 | MAP4K1 | 1.80589750 |
| 20 | VRK1 | 1.70637552 |
| 21 | IRAK4 | 1.70151150 |
| 22 | BRSK2 | 1.69421461 |
| 23 | CDK19 | 1.62297749 |
| 24 | MST4 | 1.59012744 |
| 25 | RPS6KA4 | 1.53673261 |
| 26 | MAPKAPK3 | 1.49840420 |
| 27 | TSSK6 | 1.49453634 |
| 28 | TESK2 | 1.43189334 |
| 29 | TLK1 | 1.40143908 |
| 30 | DYRK3 | 1.38186371 |
| 31 | SRPK1 | 1.36666371 |
| 32 | STK10 | 1.36103108 |
| 33 | ACVR1B | 1.26949511 |
| 34 | AURKB | 1.26922092 |
| 35 | RIPK4 | 1.24644650 |
| 36 | TAF1 | 1.24564241 |
| 37 | NEK2 | 1.23412070 |
| 38 | CDK7 | 1.22524376 |
| 39 | ZAP70 | 1.19327195 |
| 40 | SCYL2 | 1.16428493 |
| 41 | PKN2 | 1.15781496 |
| 42 | FES | 1.12953208 |
| 43 | SIK1 | 1.12329883 |
| 44 | KDR | 1.12032170 |
| 45 | TXK | 1.10850924 |
| 46 | EPHA2 | 1.09486035 |
| 47 | ILK | 1.08533492 |
| 48 | PAK4 | 1.07660381 |
| 49 | MKNK1 | 1.07213509 |
| 50 | MAP3K10 | 1.05146714 |
| 51 | BTK | 1.01912320 |
| 52 | ERN1 | 1.01403501 |
| 53 | TEC | 0.99673169 |
| 54 | MAP3K8 | 0.99243293 |
| 55 | MAP2K3 | 0.96892565 |
| 56 | IKBKE | 0.96288760 |
| 57 | PIM1 | 0.93530347 |
| 58 | TESK1 | 0.92549309 |
| 59 | KIT | 0.91672096 |
| 60 | PLK1 | 0.86081719 |
| 61 | GRK6 | 0.85340615 |
| 62 | PAK2 | 0.84320892 |
| 63 | NLK | 0.83322234 |
| 64 | NME1 | 0.81506843 |
| 65 | TAOK2 | 0.80952665 |
| 66 | ATR | 0.80264986 |
| 67 | LIMK1 | 0.80192201 |
| 68 | HCK | 0.79014021 |
| 69 | CDK4 | 0.78207360 |
| 70 | AURKA | 0.78037736 |
| 71 | MAP3K13 | 0.75777130 |
| 72 | ICK | 0.75401432 |
| 73 | CDK6 | 0.74059216 |
| 74 | CSNK2A2 | 0.73468137 |
| 75 | RPS6KA5 | 0.70950564 |
| 76 | TYK2 | 0.70117636 |
| 77 | PAK1 | 0.67441391 |
| 78 | CSF1R | 0.66775101 |
| 79 | IRAK2 | 0.65616256 |
| 80 | IKBKB | 0.65098363 |
| 81 | MARK3 | 0.63932024 |
| 82 | PTK6 | 0.63446288 |
| 83 | MAPK11 | 0.63344857 |
| 84 | MAP2K2 | 0.63311652 |
| 85 | TAOK3 | 0.62526770 |
| 86 | CLK1 | 0.61631381 |
| 87 | JAK3 | 0.61535544 |
| 88 | MAP3K3 | 0.61131798 |
| 89 | CSK | 0.61085635 |
| 90 | FGFR4 | 0.60991784 |
| 91 | PIK3CG | 0.59438784 |
| 92 | CSNK2A1 | 0.58486270 |
| 93 | CDK8 | 0.58308441 |
| 94 | TTK | 0.56456964 |
| 95 | CHEK1 | 0.55386393 |
| 96 | SIK3 | 0.55227546 |
| 97 | IRAK3 | 0.54962743 |
| 98 | BLK | 0.54415548 |
| 99 | MAP3K14 | 0.53839931 |
| 100 | MELK | 0.53707342 |
| 101 | SYK | 0.52719684 |
| 102 | TBK1 | 0.51523049 |
| 103 | TNK2 | 0.51480442 |
| 104 | DYRK1B | 0.50725391 |
| 105 | HIPK2 | 0.50304716 |
| 106 | ITK | 0.49889102 |
| 107 | CHEK2 | 0.49739788 |
| 108 | PLK3 | 0.49426831 |
| 109 | PLK4 | 0.48995979 |
| 110 | LCK | 0.48962169 |
| 111 | BRSK1 | 0.48317460 |
| 112 | CDK9 | 0.47450136 |
| 113 | PRKD2 | 0.46849201 |
| 114 | MAP3K1 | 0.45591570 |
| 115 | MAPKAPK5 | 0.45510564 |
| 116 | TGFBR2 | 0.44687780 |
| 117 | MAP3K11 | 0.44597076 |
| 118 | MAPK12 | 0.43359861 |
| 119 | LYN | 0.43139083 |
| 120 | CDK12 | 0.42905459 |
| 121 | EIF2AK2 | 0.42238205 |
| 122 | MAPKAPK2 | 0.39673886 |
| 123 | PRKCI | 0.39510913 |
| 124 | DAPK3 | 0.39401966 |
| 125 | BCKDK | 0.39293610 |
| 126 | MATK | 0.38236020 |
| 127 | GRK5 | 0.36761300 |
| 128 | BMPR1B | 0.35530467 |
| 129 | ABL2 | 0.35264987 |
| 130 | ARAF | 0.35072847 |
| 131 | STK4 | 0.34549908 |
| 132 | RPS6KA6 | 0.34334948 |
| 133 | RPS6KL1 | 0.34230010 |
| 134 | RPS6KC1 | 0.34230010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Ribosome_Homo sapiens_hsa03010 | 7.59653129 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.59972072 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.39326541 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.02666724 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 2.90275872 |
| 6 | Spliceosome_Homo sapiens_hsa03040 | 2.78881277 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.73619522 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.45082349 |
| 9 | RNA transport_Homo sapiens_hsa03013 | 2.22595089 |
| 10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.19223484 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.17905052 |
| 12 | Base excision repair_Homo sapiens_hsa03410 | 2.00610567 |
| 13 | Homologous recombination_Homo sapiens_hsa03440 | 1.99315864 |
| 14 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.95106814 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.86722958 |
| 16 | Parkinsons disease_Homo sapiens_hsa05012 | 1.80475636 |
| 17 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.80458222 |
| 18 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.78909438 |
| 19 | Cell cycle_Homo sapiens_hsa04110 | 1.51744334 |
| 20 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.47274013 |
| 21 | RNA degradation_Homo sapiens_hsa03018 | 1.30879350 |
| 22 | Huntingtons disease_Homo sapiens_hsa05016 | 1.30409096 |
| 23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.26442066 |
| 24 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.24730458 |
| 25 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.19975207 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.17731576 |
| 27 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.16601974 |
| 28 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.11715157 |
| 29 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.10133991 |
| 30 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.08041013 |
| 31 | Alzheimers disease_Homo sapiens_hsa05010 | 1.06354077 |
| 32 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.04738697 |
| 33 | Basal transcription factors_Homo sapiens_hsa03022 | 1.03281850 |
| 34 | Sulfur relay system_Homo sapiens_hsa04122 | 0.97301755 |
| 35 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.94895717 |
| 36 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.92226605 |
| 37 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91757351 |
| 38 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.90736588 |
| 39 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.89385272 |
| 40 | Purine metabolism_Homo sapiens_hsa00230 | 0.86763599 |
| 41 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.86701442 |
| 42 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.86664134 |
| 43 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.83311534 |
| 44 | Legionellosis_Homo sapiens_hsa05134 | 0.79299968 |
| 45 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.79150927 |
| 46 | Thyroid cancer_Homo sapiens_hsa05216 | 0.78065765 |
| 47 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.76654326 |
| 48 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.76608665 |
| 49 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.74970336 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.73097415 |
| 51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.70008320 |
| 52 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.68063189 |
| 53 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.67219060 |
| 54 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.66049918 |
| 55 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.61275201 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60294829 |
| 57 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.58995818 |
| 58 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.58474062 |
| 59 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58260108 |
| 60 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.58058913 |
| 61 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.57348802 |
| 62 | Measles_Homo sapiens_hsa05162 | 0.56296048 |
| 63 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.56234465 |
| 64 | Apoptosis_Homo sapiens_hsa04210 | 0.55963590 |
| 65 | HTLV-I infection_Homo sapiens_hsa05166 | 0.55911434 |
| 66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.55073287 |
| 67 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.51444152 |
| 68 | Other glycan degradation_Homo sapiens_hsa00511 | 0.51398018 |
| 69 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.50251789 |
| 70 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.49259179 |
| 71 | Asthma_Homo sapiens_hsa05310 | 0.48918169 |
| 72 | Carbon metabolism_Homo sapiens_hsa01200 | 0.46498012 |
| 73 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.46284835 |
| 74 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.46074699 |
| 75 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45969510 |
| 76 | Leishmaniasis_Homo sapiens_hsa05140 | 0.45882269 |
| 77 | Allograft rejection_Homo sapiens_hsa05330 | 0.45384058 |
| 78 | Tuberculosis_Homo sapiens_hsa05152 | 0.45146044 |
| 79 | Bladder cancer_Homo sapiens_hsa05219 | 0.45084007 |
| 80 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44809173 |
| 81 | Shigellosis_Homo sapiens_hsa05131 | 0.43742853 |
| 82 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.42337966 |
| 83 | Hepatitis B_Homo sapiens_hsa05161 | 0.41904314 |
| 84 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.40217862 |
| 85 | Hepatitis C_Homo sapiens_hsa05160 | 0.38841574 |
| 86 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.38230829 |
| 87 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.37032862 |
| 88 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.36242531 |
| 89 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35402013 |
| 90 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.35150293 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.34252234 |
| 92 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.33158423 |
| 93 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.32814144 |
| 94 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.32247266 |
| 95 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.32209817 |
| 96 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.31811416 |
| 97 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.31229601 |
| 98 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.30679024 |
| 99 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.28549433 |
| 100 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.27750629 |
| 101 | Metabolic pathways_Homo sapiens_hsa01100 | 0.27506936 |
| 102 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.27131842 |
| 103 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.27118273 |
| 104 | Colorectal cancer_Homo sapiens_hsa05210 | 0.26739990 |
| 105 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.26613945 |
| 106 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.26483661 |
| 107 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.25163123 |
| 108 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.24351937 |
| 109 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.24341944 |
| 110 | Alcoholism_Homo sapiens_hsa05034 | 0.24240531 |
| 111 | Pertussis_Homo sapiens_hsa05133 | 0.24064582 |
| 112 | Pathways in cancer_Homo sapiens_hsa05200 | 0.22352987 |
| 113 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.22133992 |
| 114 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.21500025 |
| 115 | Influenza A_Homo sapiens_hsa05164 | 0.21449442 |
| 116 | Prostate cancer_Homo sapiens_hsa05215 | 0.21402264 |
| 117 | Viral myocarditis_Homo sapiens_hsa05416 | 0.20765415 |
| 118 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.19118170 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.18581995 |
| 120 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.17414535 |
| 121 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.16896150 |
| 122 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.16431348 |
| 123 | Galactose metabolism_Homo sapiens_hsa00052 | 0.16206587 |
| 124 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.14942487 |

